Acyline

Endocrine modulation

Hormonal-axis, androgen/estrogen, or reproductive modulation

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Endocrine / hormone-modulating compound
Primary mechanism: Steroid hormone receptor or enzyme modulation
Primary market use: Endocrine modulation

Pharmacology

Molecular weight (Da): 1533.21
Oral bioavailability: Route-dependent / verify
Half-life: ~5–60 min parent peptide; analogs may be longer
Route tags: SubQ; Injectable; route-dependent
Evidence level: MCE product listing / research chemical signal
Clinical status: Research chemical/reference listing
Value-for-money score: 5 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Acyline, a GnRH peptide analogue, is a GnRH antagonist that inhibits gonadotropin and testosterone (T) levels.

Sources

https://www.medchemexpress.com/acyline.html